Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RISE Pediatric Medication Study
NCT01779375Phase 3Completed
- Sponsor
- RISE Study Group
- Start
- Jun 2013
- Primary completion
- Jul 2017
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin, insulin glargine in prediabetes, type 2 diabetes mellitus (T2DM), sponsored by RISE Study Group. Started Jun 2013; status: completed.
02
Drugs
metformininsulin glargine
03
Conditions
prediabetestype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01779375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01779375.